Broader equity markets saw notable movement in the period surrounding this report. The Nasdaq 100 added approximately $3.5 trillion in market capitalisation over four consecutive trading sessions through mid-August 2026, driven by strong corporate earnings and renewed interest in technology sectors [Brief - 2026-08-15]. CVS Health Corp. operated against this broader market backdrop during the second quarter of 2026.
For the trailing twelve months ending 30 June 2026, CVS Health reported revenue of approximately $415.1 billion, reflecting year-over-year revenue growth of 7.26% [SEC 10-Q - CVS - 2026-06-30]. Net income for the same period stood at approximately $4.9 billion, with a net margin of 1.18% and an operating margin of 1.997% [SEC 10-Q - CVS - 2026-06-30]. Gross margin was recorded at 7.06%. The company held $11.3 billion in cash against total debt of $63.5 billion. The trailing P/E ratio was 25.14, with EPS growing 188.75% year-over-year, and market capitalisation stood at approximately $121.8 billion [SEC 10-Q - CVS - 2026-06-30].
On the institutional ownership front, four notable firms opened new positions in CVS during the most recent reporting period. Citadel, AQR Capital, Millennium, and Bridgewater Associates each initiated new holdings in the stock [SEC 13F - Citadel - Q2 2026] [SEC 13F - AQR Capital - Q2 2026] [SEC 13F - Millennium - Q2 2026] [SEC 13F - Bridgewater - Q2 2026]. No insider transaction data was available for inclusion in this report. The simultaneous initiation of positions by multiple large institutional managers represents the primary trigger for this report.
The prevailing macroeconomic environment featured a 10-year US Treasury yield of 4.83% and a 2-year yield of 4.39%, reflecting a normal yield curve configuration as of the report generation date [FRED DGS10] [FRED DGS2]. The spread between the 2-year and 10-year maturities stood at approximately 44 basis points. These rate levels form part of the broader financing and discount-rate context within which CVS Health's debt load of $63.5 billion is evaluated by market participants.